4530 — Hisamitsu Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Annual cashflow statement for Hisamitsu Pharmaceutical Co, fiscal year end - February 28th, JPY millions except per share, conversion factor applied.

	2022 February 28th	2023 February 28th	2024 February 29th	2025 February 28th	2026 February 28th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	12,956	16,113	19,186	28,687	23,656
Depreciation
Amortisation
Non-Cash Items	-2,814	-3,803	-4,114	-8,938	-4,801
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	4,736	-4,534	-2,057	-7,319	-8,429
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	19,199	12,728	18,187	18,765	17,477
Capital Expenditures	-4,193	-7,908	-13,036	-13,774	-8,050
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-8,867	-15,960	10,524	31,337	-8,816
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-13,060	-23,868	-2,512	17,563	-16,866
Financing Cash Flow Items	-190	-203	-247	-390	-246
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-15,189	-14,687	-16,691	-15,850	-20,198
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-5,106	-20,822	941	23,414	-19,849